Archives of “Li Li (badminton)” tag

rss

Stocks up for the 4th straight day. NASDAQ gains 2.5%

  
Analysis, US Market
#  #  #  #  #  #  #

Dow, S&P and NASDAQ on track for the best week since April

The major stock indices closed sharply higher for the 4th consecutive day. The Dow, S&P and NASDAQ on track for the best week since April:

  • 10 of the 11 sectors of the S&P closed higher with energy dipping into the negative at the close
  • Dow closes less than 1% below its 2020 breakeven level
  • NASDAQ index is up close to 9% for the week
  • NASDAQ closes less than 2% from the all-time high
  • S&P index closes 2% from its all-time high
  • the S&P index is up 7.4% for the week (was down around 6% last week)
  • 4 straight days higher
The final numbers are showing:
  • S&P index up 67.01 points or 1.95% at 3510.45
  • NASDAQ index up 300.14 points or 2.59% at 11890.92
  • Dow industrial average up 542.52 points or 1.95% at 28390.18
Some oversize winners today included:
  • Qualcomm, +12.79%
  • FirstSolar, +8.91%
  • Papa John’s +8.12%
  • United Airlines +6.0%
  • Southwest Airlines +5.42%
  • American Airlines +5.32%
  • PayPal +5.3%
  • Caterpillar +5.12%
  • J.P. Morgan, +4.05%
  • Bank of America, +3.89%
  • Salesforce, +3.85%
Some losers today included:
  • AliBaba, -2.76%
  • Northrop Grumman, -2.6%
  • Bristol-Myers Squibb, -2.54%
  • Exxon Mobil, -2.11%
  • Lockheed Martin, -1.96%
  • Pfizer, -1.52%
  • Phillip Morris, -0.85%
  • Gilead, -0.4%
  • Snowflake, -0.3%
  • Boston Scientific,

US indices close lower but rebound into the close eases the pain

  
Analysis, US Market
#  #  #  #  #  #  #  #

NASDAQ index leads the way to the downside

The major indices are closing lower on the day but did rebounded into the close which eased some of the downside pain.
  • Dow close that is lowest level since July 31
  • Amazon, Apple close over 5% lower. Apple closes 20% below its all-time high
  • Twitter plunged 21%
  • Facebook fell -6.3%
  • Major indices post the 2nd straight monthly declines
  • Dow has it’s worst month since March
  • NASDAQ closes nearly 10% below its all-time high
  • S&P closes just 1.21% from the 2019 close
  • S&P closes 9% from all time high
The final numbers are showing:
  • S&P index fell -40.15 points or -1.21% at 3269.96
  • NASDAQ index fell -274 points or -2.45% at 10911.59
  • Dow industrial average fell 157.51 points or -0.59% at 26501.68
Looking at the ranges and changes for the major indices in North America and Europe, Portugal led the way to the upside. Other gainers were the France’s CAC, Spain’s Ibex, and Italy’s FTSE MIB. The NASDAQ index was the biggest loser for the day.
For the week,

(more…)

Amazon, Facebook, Twitter, Alphabet all come in better than expectations

  
Analysis, US Market
#  #  #  #  #  #  #
Amazon:
  • revenues $96.15 billion vs.$92.70 billion estimate
  • EPS $12.37 vs. $7.41 estimate
  • the caveat is AWS numbers came in about expectations and apparently there was favorable taxes
  • Amazon shares are trading down at $3163 after closing at $3211
Facebook
  • EPS $2.71 vs. $1.91 estimate
  • revenues $21.47 billion vs. 19.28 billion estimate
  • Facebook shares are trading down at $275 after closing at $280.83

Twitter

  • revenues 936 million vs. 777 million estimate
  • earnings-per-share $0.19 adjusted vs. $0.06 estimate
  • Twitter is trading down at $46.33 after closing at $52.43
Alphabet
  • revenues 46.17 billion vs. 42.90 billion estimate
  • earnings-per-share $16.40 vs. $11.29 estimate
  • Alphabet shares are trading up at $1638 after closing at $1556.88
Starbucks
  • earnings-per-share $0.51 vs. $0.31 estimate
  • revenues $6.2 billion worth of $6.06 billion estimate
  • Starbucks shares are trading up at $89.40 after closing at$88.30

Fauci on the news wires – sees a whole lot of pain if COVID-19 trends do not change

  
  Analysis
#  #  #

Dr Fauci, Director of the National Institute of Allergy and Infectious Diseases in the US, in an interview with CNBC

  • sees a whole lot of pain if covid trends don’t change
  • mask-wearing, distancing would have a big impact
  • very little appetite
  • for lockdown in US
  • changes need to be made to combat in US
  • doubtful White House will mandate national mask-wearing

Major indices plunge on Covid/election fear. Close near session lows

  
Analysis, US Market
#  #

Big day today on the earnings front

The major indices fell sharply on Covid/election fears. European countries imposed new restrictions. Case count continue to rise putting pressure on hospitals. A lack of a coronavirus stimulus deal in the US is also weighing. Finally, uncertainty about the upcoming election is also frightened traders. The volatility index (Vix index )rose by 19.31% to close to 40.

Some of the highlights in the numbers today
  • Dow closes down for the 4th consecutive day
  • Dow has the longest losing streak since February
  • Dow closes at the lowest level since July 31
  • Dow closed below its 100 day moving average at 27250.30. Approaches its 200 day moving average at 26226.46
  • S&P has a 3 day losing streak
  • S&P sees all 11 sectors moved to the downside
  • S&P index closed below its 100 day moving average at 3306.05
  • NASDAQ index closed below its 50 day moving average at 11313.65, but above its 100 day moving average at 10870.86
The final numbers are showing:
  • S&P index fell -119.51 points or -3.52% to 3271.17.
  • The NASDAQ index fell by -426.48 points or -3.73% to 11004.86.
  • Dow industrial average fell minus hundred 42.18 points or -3.43% to 26520.74

WHO on Remdesiver vaccine disappointment – looking at alternatives to trial

  
  Analysis
#  #  #  #
More from the WHO:
  • says solidarity therapeutics trial produces conclusive evidence on effectiveness of repurposed drugs for covid-19 in record time
  • says interim remdesivir, hydroxychloroquine, lopinavir/ritonavir and interferon regimens appeared to have little or no effect on 28-day mortality
  • who-interim results in trial indicate remdesivir appeared to have little or no effect on 28day mortality or in-hospital course of covid-19 in patients
  • study, which spans over 30 countries, looked at effects of treatments on overall mortality, initiation of ventilation, duration of hospital stay
  • newer antiviral drugs, immunomodulators and anti-sars cov-2 monoclonal antibodies are now being considered for evaluation at solidarity trial

Headlines via Reuters

Major indices close lower for the 2nd consecutive day

  
Analysis, US Market
#  #  #  #  #  #

NASDAQ leads the way lower

The major indices close lower for the 2nd consecutive day. The NASDAQ index was the weakest

of the majors today.

Some highlights:
  • S&P and NASDAQ index is trading lesson 3% from the all-time high
  • Stocks have their first 2 day losing streak since September 18
  • The Dow industrial average turned back for 2020
  • UnitedHealth care was the biggest drag on the Dow
  • Russell 2000 of small-cap stocks fell by -0.93%
The final numbers are showing:
  • The S&P index fell -23.32 points or -0.66% to 3488.61. The high price reached 3527.94. The low price extended to 3480.55
  • The NASDAQ index fell -95.166 points or -0.80% to 11768.73. It’s high price reached 11939.91. The low price extended to 11714.35
  • The Dow industrial average closed down -165.83 points or -0.58% to 28513.98. The high price reached 28792.56. The low extended to 28461.73.

US indices close sharply higher. Dow has best day since July

  
Analysis, US Market
#  #  #  #  #  #  #  #  #  #

S&P index has all sectors in the green

The major US stock indices are closing sharply higher on hopes for targeted coronavirus aid

  • All 30 Dow stocks closed in the green
  • All 11 S&P sectors closed higher
  • Dow is up nearly 600 points at the highs
  • Stocks close higher to last 3 trading days
  • Dow closes at the highest level since September 2
  • Dow has best day since July
  • The gains today erased the losses (and then some) from yesterday. Yesterday the S&P fell -1.4%. The NASDAQ index fell -1.57% and the Dow industrial average fell by -1.34%.
The final numbers are showing:
  • S&P index rose 58.47 points or 1.74% at 3419.43. The high reached 3426.26. The low extended to 334.56
  • NASDAQ index closed up 209.99 points or 1.88% at 11364.59. The high reached 11380.55. The low reached 11258.35
  • Dow rose 530.7 points or 1.91% at 28303.46. The hi reached 28369.66. The low extended to 27971.36
Some winners include:
  • First Solar, +7.08%
  • Netflix, +5.71%
  • American Express, +4.35%
  • United Airlines, +4.30%
  • Corning, +4.25%
  • Beyond Meat, +4.0%
  • Salesforce, +3.89%
  • Western Digital, +3.56%
  • Slack, +3.53%
  • Boeing, +3.16%
The worst performing Dow stocks include:
  • Verizon, +0.2%
  • Walmart, +0.2%
  • Merck and Company, +0.51%
Other losers today included:
  • Exxon Mobil, -2.49%
  • GoodRx, -1.14%
  • Lyft, -0.49%
  • Papa John’s, -0.38%
  • Crowdstrike, -0.34%
  • Facebook, -0.27%
  • Raytheon, unchanged

UK coronavirus – PM Johson considering imposing tougher lockdown restrictions

  
  Analysis
#  #  #  #  #  #  #

UK media (Sun) reporting Boris Johnson is pondering even tougher restrictions

  • tougher lockdown restrictions for millions of people in the north of England
Due to the continued surge in COVID-19 cases.
More from the report:
  • there is “simply no reasonable alternative” to restrictions
  • Pubs and restaurants face closure in Liverpool, Manchester and Newcastle
  • Some shops could also be forced to shut
  • workplaces and schools would remain open.
  • A No 10 source said: “The numbers are going the wrong way, and there will come a point very soon where we simply have to do more.”

Moderna says its coronavirus vaccine will not be ready until 2021

  
  Analysis
#  #  #  #  #  #  #  #

Moderna CEO Stéphane Bancel statements on Wednesday, carried in the Financial Times overnight ICYMI.

  • will not seek emergency authorization for Food and Drug Administration approval for its vaccine to use in frontline medical workers and at-risk individuals until Nov. 25 at the earliest.
  • company would not seek FDA approval for use in the general population until late January
  • If the vaccine is proven safe and effective, approval is unlikely to come until at least late March or early April
Link to FT, may be gated.
Go to top